GeneDx Holdings Corp. Class A
(NASDAQ: WGS)

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

161.328

-0.622 (-0.38%)
Range 158.540 - 162.720   (2.64%)
Open 162.720
Previous Close 161.950
Bid Price 7.330
Bid Volume 14
Ask Price 7.800
Ask Volume 10
Volume 26,958
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:07.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis